BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 1327242)

  • 1. Inactivation of Murine Norovirus Suspended in Organic Matter Simulating Actual Conditions of Viral Contamination.
    Jubinville E; Girard M; Trudel-Ferland M; Fliss I; Jean J
    Food Environ Virol; 2021 Dec; 13(4):544-552. PubMed ID: 34328631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood substitutes. Haemoglobin therapeutics in clinical practice.
    Baron JF
    Crit Care; 1999; 3(5):R99-102. PubMed ID: 11094489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb) for viral inactivation.
    Azari M; Ebeling A; Baker R; Burhop K; Camacho T; Estep T; Guzder S; Marshall T; Rohn K; Sarajari R
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):577-82. PubMed ID: 9844723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb) for viral inactivation--effect of crosslinking.
    Azari M; Catarello J; Burhop K; Camacho T; Ebeling A; Estep T; Guzder S; Krause K; Marshall T; Rohn K; Sarajari R; Boose JA; Gauvin G; Horner R; Lu B; Pearson L; Vacante D
    Artif Cells Blood Substit Immobil Biotechnol; 1997 Nov; 25(6):521-6. PubMed ID: 9352057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and validation of virus removal by ultrafiltration during the production of diaspirin crosslinked haemoglobin (DCLHb).
    Azari M; Boose JA; Burhop KE; Camacho T; Catarello J; Darling A; Ebeling AA; Estep TN; Pearson L; Guzder S; Herren J; Ogle K; Paine J; Rohn K; Sarajari R; Sun CS; Zhang L
    Biologicals; 2000 Jun; 28(2):81-94. PubMed ID: 10885615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diaspirin crosslinked hemoglobin (DCLHb) polymerization.
    Hai TT; Nelson D; Pereira D; Srnak A
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):923-31. PubMed ID: 7994419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of diaspirin cross-linked human hemoglobin solutions.
    Estep TN; Gonder J; Bornstein I; Aono F
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):603-9. PubMed ID: 1391483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B viral clearance studies using duck virus model.
    Long Z; Sun CS; White EM; Horowitz B; Sito AF
    Dev Biol Stand; 1993; 81():163-8. PubMed ID: 8174798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of virus inactivation by heat treatment in the manufacture of diaspirin crosslinked hemoglobin.
    Farmer M; Ebeling A; Marshall T; Hauck W; Sun CS; White E; Long Z
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):429-33. PubMed ID: 1327242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: an overview.
    Chang TM
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):159-79. PubMed ID: 1391433
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.